Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Protein tyrosine kinase /JAK / STAT >  JAK inhibitors >  JAK3 Inhibitor

JAK3 Inhibitor

Basic information Safety Supplier Related

JAK3 Inhibitor Basic information

Product Name:
JAK3 Inhibitor
Synonyms:
  • JAK3 Inhibitor
  • 2-Bromo-4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenol
  • Phenol, 2-bromo-4-[(6,7-dimethoxy-4-quinazolinyl)amino]-
  • 4-(3'-Bromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline WHI-P 154
  • 2-Bromo-4-((6,7-dimethoxyquinazolin-4-yl)amino)phenol
  • JAK3 Inhibitor II - CAS 211555-04-3 - Calbiochem
  • CS-1516
  • whi-p154cas
CAS:
211555-04-3
MF:
C16H14BrN3O3
MW:
376.2
EINECS:
809-014-9
Product Categories:
  • Inhibitors
  • Inhibitor
  • JAK/STAT
  • JAK
  • STAT
Mol File:
211555-04-3.mol
More
Less

JAK3 Inhibitor Chemical Properties

Melting point:
230 °C
Boiling point:
470.3±45.0 °C(Predicted)
Density 
1.576±0.06 g/cm3(Predicted)
storage temp. 
-20°C
solubility 
DMSO: soluble1mg/mL, clear (warmed)
pka
8.57±0.31(Predicted)
form 
powder
color 
white to brown
InChIKey
CBIAKDAYHRWZCU-UHFFFAOYSA-N
CAS DataBase Reference
211555-04-3
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22-36/37/38
Safety Statements 
26
RIDADR 
UN 2811 6.1 / PGIII
WGK Germany 
3
HS Code 
2933.59.8000
More
Less

JAK3 Inhibitor Usage And Synthesis

Description

WHI-P154 is a quinazoline derivative that exhibits immunosuppressive effects by selectively inhibiting JAK3 (IC50 = 1.8 μM versus IC50s > 10 μM for JAK1 and JAK2). It has been reported to inhibit additional kinases including EGFR (IC50 = 4 nM) and VEGFR as well as the non-receptor tyrosine kinases, Abl, Lck, and Src. WHI-P154 is cytotoxic to human glioblastoma cells (IC50 = 813 nM) and has been used to induce the differentiation of neuronal precursor cells.

Uses

WHI-P154 is a potent JAK3 inhibitor with IC50 of 1.8 μM and also inhibits EGFR with IC50 of 4 nM.

Uses

WHI-P154 can act as antileukemic agent with apoptosis inducing activity.

Biochem/physiol Actions

WHI-P154 is a specific inhibitor of JAK3 (IC50 = 1.8 μM) with no inhibitory activity against JAK1 or JAK2. WHI-P154 enhances myogenic differentiation of C2C12 mouse myoblast cells, and induces differentiation of neural progenitor cells. The compound WHI-P154 dose dependently inhibits expression of iNOS and NO production in LPS-challenged macrophages.

in vitro

kinase assays show that whi-p154 is not a specific inhibitor. besides jak3, it also inhibits many other kinases, including egfr, abl, lck, src and vegfr. whi-p154 inhibits egfr with ic50 value of 4nm. the specificity of whi-p154 has not been shown in cell-based assays either [1].

storage

Store at RT

References

[1] changelian ps, moshinsky d, kuhn cf, flanagan me, munchhof mj, harris tm, whipple da, doty jl, sun j, kent cr, magnuson ks, perregaux dg, sawyer ps, kudlacz em. the specificity of jak3 kinase inhibitors. blood. 2008 feb 15;111(4):2155-7.
[2] narla rk, liu xp, myers de, uckun fm. 4-(3'-bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells. clin cancer res. 1998 jun;4(6):1405-14.

JAK3 InhibitorSupplier

Angel Pharmatech, Ltd. Gold
Tel
17317130613
Email
3358272972@qq.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
VDM Biochemicals
Tel
0330-2528181
Email
sales@vdmbio.com